Numerous biologic processes and such diseases as cancer depend on activation of tyrosine kinase receptors. The RET tyrosine kinase receptor was discovered two decades ago as a transforming gene and was subsequently implicated in the formation of papillary and medullary thyroid carcinoma. This article examines the data about the mechanism of activation of downstream signal transduction pathways by RET oncoproteins. Collectively, these findings have advanced the understanding of the processes underlying thyroid carcinoma formation
RET/PTC oncogenes are highly prevalent in papillary thyroid carcinoma, an indolent and well-differen...
The activation of the RET proto-oncogene contributes to the development of human cancers in two dier...
The ret oncogene frequently has been found activated in papillary thyroid carcinomas. A previous cha...
Numerous biologic processes and such diseases as cancer depend on activation of tyrosine kinase rece...
RET is the receptor for glial-derived neurotrophic factor growth factors. It is a paradigm of a sing...
Papillary thyroid carcinoma (PTC) is frequently associated with RET gene rearrangements that generat...
RET (rearranged during transfection) is a receptor tyrosine kinase involved in the development of ne...
Since the discovery of the RET receptor tyrosine kinase in 1985, alterations of this protein have be...
Mutations that produce oncogenes with dominant gain of function target receptor protein tyrosine kin...
The RET gene encodes a single-pass transmembrane receptor tyrosine kinase. RET is the oncogene that ...
protooncogene, a receptor tyrosine kinase, have been iden-tified as a cause of medullary thyroid car...
Mutations that produce oncogenes with dominant gain of function target receptor protein tyrosine kin...
RET gene rearrangements (RET/PTCs) represent together with BRAF point mutations the two major groups...
Medullary thyroid cancer (MTC) is a neuroendocrine tumor that arises from the parafollicular C-cells...
RET/PTC oncogenes are highly prevalent in papillary thyroid carcinoma, an indolent and well-differen...
The activation of the RET proto-oncogene contributes to the development of human cancers in two dier...
The ret oncogene frequently has been found activated in papillary thyroid carcinomas. A previous cha...
Numerous biologic processes and such diseases as cancer depend on activation of tyrosine kinase rece...
RET is the receptor for glial-derived neurotrophic factor growth factors. It is a paradigm of a sing...
Papillary thyroid carcinoma (PTC) is frequently associated with RET gene rearrangements that generat...
RET (rearranged during transfection) is a receptor tyrosine kinase involved in the development of ne...
Since the discovery of the RET receptor tyrosine kinase in 1985, alterations of this protein have be...
Mutations that produce oncogenes with dominant gain of function target receptor protein tyrosine kin...
The RET gene encodes a single-pass transmembrane receptor tyrosine kinase. RET is the oncogene that ...
protooncogene, a receptor tyrosine kinase, have been iden-tified as a cause of medullary thyroid car...
Mutations that produce oncogenes with dominant gain of function target receptor protein tyrosine kin...
RET gene rearrangements (RET/PTCs) represent together with BRAF point mutations the two major groups...
Medullary thyroid cancer (MTC) is a neuroendocrine tumor that arises from the parafollicular C-cells...
RET/PTC oncogenes are highly prevalent in papillary thyroid carcinoma, an indolent and well-differen...
The activation of the RET proto-oncogene contributes to the development of human cancers in two dier...
The ret oncogene frequently has been found activated in papillary thyroid carcinomas. A previous cha...